The POPULUS-1 Study is an early-stage clinical research study (Phase 1) testing a new treatment called RXIM002 in people with certain autoimmune blood disorders that have come back or have not responded to previous treatments. The study will first include people with immune thrombocytopenia (ITP), the most common autoimmune blood disorder.
Australia, USA
https://clinicaltrials.gov/study/NCT07765966?term=NCT07765966&viewType=Card&rank=1
Actively Recruiting
Platelet Disorder Support Association
8751 Brecksville Road Suite 150
Cleveland, OH 44141
📞440.746.9003 | ✉ pdsa@pdsa.org | pdsa.org
The Platelet Disorder Support Association is a 501(c)(3) organization and donations are tax deductible to the fullest extent allowed by law.
© Copyright 1997 - 2026, Platelet Disorder Support Association. All rights reserved.
IMPORTANT!
The Platelet Disorder Support Association does not provide medical advice or endorse any medication, vitamins or herbs. The information contained herein is not intended nor implied to be a substitute for professional medical advice and is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment, discontinuing an existing treatment and to discuss any questions you may have regarding your unique medical condition.
